![James Dentzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Dentzer
Algemeen Directeur bij
CURIS, INC.
Vermogen: 116 949 $ op 31-05-2026
Profiel
James E.
Dentzer is President, Chief Executive Officer & Director at Curis, Inc. since 2019 and Independent Director at Imunon, Inc. since 2022.
Former roles include Chief Financial Officer-DuPont Flooring Systems at EIDP, Inc., Controller at Biogen, Inc. from 2003 to 2006, Chief Financial Officer at Amicus Therapeutics, Inc. from 2006 to 2009, Chief Financial Officer at Valeritas, Inc. from 2010 to 2013, and Chief Financial Officer at Dicerna Pharmaceuticals, Inc. from 2013 to 2015.
Education includes undergraduate studies at Boston College and an MBA from The University of Chicago Booth School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CURIS, INC. 0,38% | 01-05-2026 | 148.730 ( 0,38% ) | 84 330 $ | 31-05-2026 |
IMUNON, INC. 0,59% | 22-05-2026 | 14.963 ( 0,59% ) | 32 619 $ | 31-05-2026 |
Actieve functies van James Dentzer
| Bedrijven | Functie | Begin |
|---|---|---|
| CURIS, INC. | Algemeen Directeur | 24-09-2018 |
| IMUNON, INC. | Directeur/Bestuurslid | 03-09-2022 |
Eerdere bekende functies van James Dentzer
| Bedrijven | Functie | Einde |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 15-12-2015 |
| VALERITAS INC | Financieel Directeur/CFO | 01-12-2013 |
| AMICUS THERAPEUTICS, INC. | Financieel Directeur/CFO | 29-10-2009 |
| BIOGEN INC. | Comptroller/Controller/Auditor | - |
| E I DU PONT DE NEMOURS AND CO | Corporate Officer/Principal | - |
Opleiding van James Dentzer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
56
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries Manufactures and sells seed & crop protection products | Process Industries |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
